arsenic has been researched along with Metabolic Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Deng, P; Gao, P; Gong, M; He, M; He, Z; Li, Y; Lin, M; Lu, M; Lu, Y; Ma, Q; Pi, H; Qin, S; Xu, Y; Yang, L; Yang, Z; Yu, Z; Zhang, H; Zhang, K; Zhang, L; Zhou, C; Zhou, Z | 1 |
| Chaisatra, K; Hunsonti, P; Navasumrit, P; Ngaotepprutaram, T; Ruchirawat, M; Srisuporn, P | 1 |
| Chi, L; Lai, Y; Leng, J; Liu, CW; Lu, K; Ru, H; Tu, P; Xue, J | 1 |
| Barrett, JR | 1 |
| BIRCHALL, R; CHRISTIANSON, HB | 1 |
| Fabiani, P | 1 |
6 other study(ies) available for arsenic and Metabolic Diseases
| Article | Year |
|---|---|
SOX2 modulated astrocytic process plasticity is involved in arsenic-induced metabolic disorders.
Topics: Animals; Arsenic; Hypothalamus; Metabolic Diseases; Mice; Pro-Opiomelanocortin; Proto-Oncogene Proteins c-akt | 2022 |
Arsenic exposure alters the expression of genes related to metabolic diseases in differentiated adipocytes and in newborns and children.
Topics: Adipocytes; Adipokines; Arsenic; Arsenites; Cell Differentiation; Child; Female; Humans; Infant, Newborn; Inflammation; Metabolic Diseases; PPAR gamma; Pregnancy; RNA, Messenger | 2023 |
Serum Metabolomics Reveals That Gut Microbiome Perturbation Mediates Metabolic Disruption Induced by Arsenic Exposure in Mice.
Topics: Animals; Arsenic; Bacterial Infections; Gastrointestinal Microbiome; Mass Spectrometry; Metabolic Diseases; Metabolome; Metabolomics; Mice; Serum | 2019 |
Arsenic Exposure and the Western Diet: A Recipe for Metabolic Disorders?
Topics: Arsenic; Diet; Diet, Western; Environmental Exposure; Humans; Metabolic Diseases | 2016 |
NEPHROCUTANEOUS SYNDROMES.
Topics: Amyloidosis; Anemia; Anemia, Sickle Cell; Angiokeratoma; Arachnodactyly; Arsenic; Blood Protein Disorders; Collagen Diseases; Dermatology; Drug Hypersensitivity; Ehlers-Danlos Syndrome; Glomerulonephritis; Humans; Kidney Diseases; Leukemia; Lupus Erythematosus, Systemic; Marfan Syndrome; Metabolic Diseases; Multiple Myeloma; Neurofibromatoses; Pseudoxanthoma Elasticum; Purpura; Pyelonephritis; Skin Neoplasms; Toxicology; Tuberous Sclerosis; Vascular Diseases | 1964 |
[Diseases due to drug deposits].
Topics: Antihypertensive Agents; Antimalarials; Arsenic; Benzofurans; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Metabolic Diseases; Pharmaceutical Preparations; Phenothiazines; Phosphates; Silver; Thorium Dioxide | 1972 |